⛑️ Cryptocurrency Meets Biotech
Vibe Bio, through a DAO, aims to cure rare diseases by connecting stakeholders and funding research.
Today's Highlights
- Vibe Bio - revolutionizing rare disease research with cryptocurrency
- Today's Infographic
- In Other News - a few interesting developments we're tracking
Vibe Bio - Revolutionizing Rare Disease Research with Cryptocurrency
Alok Tayi, along with co-founder Joshua Forman, established Vibe Bio after Tayi's daughter was born with a disease that had limited treatment options despite being well-understood. Recognizing the urgent need for innovative solutions, they founded Vibe Bio with the aim of addressing rare diseases.
Vibe Bio envisions using a decentralized autonomous organization, known as a DAO, to create an online community that connects various stakeholders interested in curing rare diseases, including patients, researchers, and investors. Through this community, members can collaborate, propose projects, and provide funding. Each project will undergo rigorous evaluation by scientists and financial experts. To facilitate this, Vibe Bio has launched the $VIBE governance token, a form of cryptocurrency. The company intends to initially fund these projects through the sales of $VIBE tokens. In the event that a project leads to the commercialization or licensing of a potential therapy, the DAO will generate revenue that can be reinvested in future research.
Vibe Bio has already established two independent biotechnology companies dedicated to rare diseases. One focuses on Lafora disease, a rare form of epilepsy, in collaboration with the patient advocacy organization Chelsea's Hope. The other is dedicated to neurofibromatosis type 2, a condition characterized by the formation of benign tumors in the nervous system, and was founded in partnership with NF2 Biosolutions. In both partnerships, the intellectual property resulting from these ventures will be owned by the respective independent biotechnology companies. This arrangement allows for focused research and development efforts specific to each disease while leveraging the expertise and resources of Vibe Bio and its partners.
Vibe Bio has raised a total of $12M in funding.
🧐 Today's Infographic
In Other News
Nikhilesh De, Krisztian Sandor and Lyllah Ledesma
Amitoj Singh
Will Izuchukwu